To test whether the enzymatic activities SPATA5 are required for viral infection, we inactivated ATPase activity by introducing single (glutamic acid to glutamine) and double (2×) Walker B mutations in the two ATPase domains (Fig. 8E). This evidence concerns the gene AFG2A and viral infectious disease.